View Clinical Trial (Medical Research Study)

A Phase I/II Study of HE3235 in Patients With Prostate Cancer - NCT00716794-10065(Clinical Trial 231225)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  New York
State:  
NY
Zip Code: 10065
Conditions: Prostate Cancer
Purpose: This is a phase I/II, open-label, dose escalation study of HE3235 administered orally to patients with advanced prostate cancer who have failed hormone therapy and at least one taxane based chemotherapy regimen.
Study summary:
Criteria: Main Inclusion Criteria: - Patient is male and at least 18 years of age, at the time of screening; - Patient has metastatic disease (any T, any N, M1); - Patient has failed at least 1 taxane regimen; or Patient has symptomatic or asymptomatic CRPC and is chemotherapy-naïve - Patient has histologically or cytologically confirmed adenocarcinoma of the prostate; - Patient has progression of disease despite adequate hormone therapy, demonstrated by one of the following: - PSA level of at least 2 ng/ml that has risen on at least 2 successive occasions, at least 1 week apart. - Evaluable disease progression by modified RECIST (Response Evaluation Criteria in Solid Tumors) criteria; - Progression of metastatic bone disease on bone scan with > 2 new lesions - Patient has ECOG (Eastern Cooperative Oncology Group) performance status of 0-2; Main Exclusion Criteria: - Patient has symptomatic parenchymal brain metastases or active epidural disease requiring whole-brain irradiation Treated epidural disease is allowed - Patient has active infection; - Patient having a history of clinically significant cardiovascular disease (such as CHF), clinically significant hepatic, respiratory or renal abnormalities; - Patient who has any clinically significant abnormalities in laboratory results at screening - Patient who has a history of clinically significant neurological or psychiatric condition; Additional criteria are applicable to expansion cohorts.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: February 17, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.